Latest Healthcare Research Reports

Tag: prenatal testing And newborn screening industry report

  • Prenatal Testing & Newborn Screening Market Outlook Assessing Future Opportunities And Growth Prospects

    Prenatal Testing & Newborn Screening Market Outlook Assessing Future Opportunities And Growth Prospects

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    By 2030, How Much Growth In Market Size Is Expected For The Prenatal Testing & Newborn Screening Market?

    The prenatal testing & newborn screening market size has experienced swift expansion in recent years. It is projected to increase from $6.98 billion in 2025 to $7.84 billion in 2026, at a compound annual growth rate (CAGR) of 12.3%. This historical growth can be attributed to the broadening of public health screening initiatives, a rise in institutional births, the accessibility of neonatal care facilities, an increasing focus on early disease identification, and enhancements in diagnostic testing coverage.

    The prenatal testing & newborn screening market size is anticipated to experience substantial growth in the upcoming years. It is projected to expand to $12.22 billion by 2030, achieving a compound annual growth rate (CAGR) of 11.8%. This expansion during the forecast period is driven by the increasing implementation of national screening mandates, the rising embrace of digital diagnostic platforms, growing financial commitments to maternal and child healthcare, a heightened focus on preventive healthcare models, and the expanding application of AI-assisted diagnostics. Significant trends during this period are expected to include the increasing integration of prenatal and newborn screening programs, a rise in the use of combined screening and diagnostic technologies, the wider adoption of early intervention protocols, the scaling up of automated screening workflows, and an intensified focus on comprehensive, population-wide screening.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3350&type=smp

    Which Significant Factors Are Encouraging Growth In The Prenatal Testing & Newborn Screening Market?

    The significant occurrence of genetic disorders in babies has played a role in expanding the prenatal testing & newborn screening market. The World Health Organization identifies genetic diseases such as Thalassemia, Sickle Cell Anemia, Hemophilia, Cystic Fibrosis, Tay Sachs disease, Fragile X Syndrome, and Huntington’s disease. Sickle cell anemia is a widespread genetic condition impacting millions globally, especially prevalent in populations with ancestry from Africa, America, Cuba, Central America, Saudi Arabia, and India. A study conducted at Rady Children’s Hospital, as reported by the US-based Rady Children’s Institute for Genomic Medicine in February 2023, revealed that 41% of infant fatalities were due to single-locus (Mendelian) genetic disorders. This elevated incidence of genetic conditions in infants has spurred the demand for the prenatal testing and newborn screening market.

    How Are Different Segment Groups Identified Within The Prenatal Testing & Newborn Screening Market?

    The prenatal testing & newborn screening market covered in this report is segmented –

    1) By Diagnostic Type: Non-Invasive, Invasive

    2) By Technology: Screening Technology, Diagnostic Technology

    3) By End User: Hospitals, Diagnostic centers

    Subsegments:

    1) By Non-Invasive: Blood Tests (Cell-Free DNA Testing), Ultrasound, Maternal Serum Screening

    2) By Invasive: Amniocentesis, Chorionic Villus Sampling (CVS), Cordocentesis

    Which Trends Are Expected To Shape The Prenatal Testing & Newborn Screening Market?

    Leading companies within the prenatal DNA sequencing market are adopting a strategic alliance approach to enhance the integration of technology and expand their market reach. A strategic partnership typically signifies a collaborative relationship among two or more organizations that combine their resources, expertise, and efforts to achieve shared goals or objectives. For instance, in December 2023, BillionToOne, a US-based precision diagnostics company, formed a partnership with a Johnson & Johnson company, a US-based pharmaceutical company, for the AZALEA Phase 3 clinical trial concerning nipocalimab. This trial focuses on pregnancies at risk for severe hemolytic disease of the fetus and newborn (HDFN). BillionToOne will provide its UNITY Fetal Antigen Non-invasive Prenatal Test (UNITY Fetal Antigen CTA) to screen participants and determine their eligibility. HDFN is a rare condition caused by blood type incompatibility between the pregnant individual and the fetus, potentially leading to life-threatening anemia.

    Who Are The Key Market Participants In The Prenatal Testing & Newborn Screening Market?

    Major companies operating in the prenatal testing & newborn screening market are PerkinElmer Inc, Laboratory Corporation Of America Holdings, Natera Inc, Invitae Corporation, Centogene AG, Cradle Genomics Inc, Roche Diagnostics International AG, Quest Diagnostics Incorporated, Baebies Inc, Progenity Inc, Ravgen Inc, Strand Life Sciences Pvt Ltd, Eurofins Scientific, Illumina Inc, Agilent Technologies Inc, Thermo Fisher Scientific Inc, F Hoffmann La Roche Ltd, Bio Rad Laboratories Inc, Siemens Healthineers AG, BGI Group, QIAGEN NV, Ariosa Diagnostics Inc, Verinata Health Inc, Counsyl A Myriad Company, GenPath Diagnostics, Sonic Healthcare Limited, Cepheid A Danaher Company

    Access The Complete Prenatal Testing & Newborn Screening Market Report:

    https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report

    Which Geographic Region Represents The Largest Prenatal Testing & Newborn Screening Market Share?

    North America was the largest region in the prenatal testing & newborn screening market in 2025. Western Europe was the second largest region in the prenatal testing and newborn screening market. The regions covered in the prenatal testing & newborn screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Access Prenatal Testing & Newborn Screening Market Report for Deeper Competitive Insights

    https://www.thebusinessresearchcompany.com/customise?id=3350&type=smp

    Browse Through More Reports Similar to the Global Prenatal Testing & Newborn Screening Market 2026, By The Business Research Company

    Dna Sequencing Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/dna-sequencing-global-market-report

    Next Generation Sequencing Market 2026

    https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market

    Protein Sequencing Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/protein-sequencing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Advancements in newborn screening technologies are shaping the prenatal testing and newborn screening market

    Advancements in newborn screening technologies are shaping the prenatal testing and newborn screening market

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    How Much Will The Market Value Of The Prenatal Testing & Newborn Screening Market Grow Between 2026 And 2030?

    The prenatal testing & newborn screening market’s size has observed rapid expansion in recent years. It is projected to expand from $6.98 billion in 2025 to $7.84 billion by 2026, showing a compound annual growth rate (CAGR) of 12.3%. The growth witnessed during the historic period is attributable to the broadening of public health screening initiatives, a rise in institutional births, the availability of neonatal care facilities, a heightened focus on early disease detection, and improvements in diagnostic testing coverage.

    The prenatal testing & newborn screening market is poised for significant expansion in the coming years. Projections indicate its value will reach $12.22 billion by 2030, demonstrating a robust compound annual growth rate (CAGR) of 11.8%. This anticipated growth during the forecast period is primarily driven by several factors, including the increasing scope of national screening mandates, the growing embrace of digital diagnostic platforms, rising investments directed towards maternal and child healthcare, a heightened emphasis on preventive healthcare models, and the expanding application of AI-assisted diagnostics. Key trends expected over the forecast period encompass the increasing integration of prenatal and newborn screening programs, a rising utilization of combined screening and diagnostic technologies, the growing implementation of early intervention protocols, the expansion of automated screening workflows, and an enhanced focus on comprehensive population-wide screening initiatives.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3350&type=smp

    What Major Factors Are Driving The Prenatal Testing & Newborn Screening Market Forward?

    The significant occurrence of genetic illnesses in infants has fueled the expansion of the prenatal testing & newborn screening market. The World Health Organization identifies various genetic conditions, including Thalassemia, Sickle Cell Anemia, Hemophilia, Cystic Fibrosis, Tay Sachs disease, Fragile X Syndrome, and Huntington’s disease. Sickle cell anemia, a widespread genetic disorder impacting millions globally, is notably prevalent among populations with ancestry from Africa, America, Cuba, Central America, Saudi Arabia, and India. Illustratively, a study conducted at Rady Children’s Hospital by the US-based Rady Children’s Institute for Genomic Medicine in February 2023 revealed that single-locus (Mendelian) genetic diseases accounted for 41% of infant fatalities. This elevated incidence of genetic conditions in babies has thus spurred the demand for the prenatal testing and newborn screening market.

    What Are The Different Segment Types In The Prenatal Testing & Newborn Screening Market Segment Breakdown?

    The prenatal testing & newborn screening market covered in this report is segmented –

    1) By Diagnostic Type: Non-Invasive, Invasive

    2) By Technology: Screening Technology, Diagnostic Technology

    3) By End User: Hospitals, Diagnostic centers

    Subsegments:

    1) By Non-Invasive: Blood Tests (Cell-Free DNA Testing), Ultrasound, Maternal Serum Screening

    2) By Invasive: Amniocentesis, Chorionic Villus Sampling (CVS), Cordocentesis

    Which Trends Are Impacting The Progress Of The Prenatal Testing & Newborn Screening Market?

    Companies operating within the prenatal testing & newborn screening market are concentrating on developing newborn screening devices to improve the early identification of genetic, metabolic, and other health conditions, thereby facilitating prompt interventions and better health outcomes for newborns. A newborn screening point-of-care device is designed to deliver faster, more accessible, and cost-effective screening for newborns, supporting the seven standard newborn screening tests conducted globally. For instance, in September 2023, Mylab Discovery Solutions Pvt. Ltd., an Indian-based company, launched MyNeoShield, a newborn screening point-of-care device. MyNeoShield is engineered to be low-cost, projected to be about one-fifth the price of existing solutions, which often range from ₹50 lakhs to ₹7 crores. By bringing testing directly to healthcare providers, MyNeoShield aims to enhance access to critical health services for newborns, particularly in underserved regions.

    Who Are The Well-Known Companies In The Prenatal Testing & Newborn Screening Market?

    Major companies operating in the prenatal testing & newborn screening market are PerkinElmer Inc, Laboratory Corporation Of America Holdings, Natera Inc, Invitae Corporation, Centogene AG, Cradle Genomics Inc, Roche Diagnostics International AG, Quest Diagnostics Incorporated, Baebies Inc, Progenity Inc, Ravgen Inc, Strand Life Sciences Pvt Ltd, Eurofins Scientific, Illumina Inc, Agilent Technologies Inc, Thermo Fisher Scientific Inc, F Hoffmann La Roche Ltd, Bio Rad Laboratories Inc, Siemens Healthineers AG, BGI Group, QIAGEN NV, Ariosa Diagnostics Inc, Verinata Health Inc, Counsyl A Myriad Company, GenPath Diagnostics, Sonic Healthcare Limited, Cepheid A Danaher Company

    Get The Full Prenatal Testing & Newborn Screening Market Report:

    https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report

    Which Region Holds The Highest Market Share In The Prenatal Testing & Newborn Screening Market?

    North America was the largest region in the prenatal testing & newborn screening market in 2025. Western Europe was the second largest region in the prenatal testing and newborn screening market. The regions covered in the prenatal testing & newborn screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Prenatal Testing & Newborn Screening Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report

    Browse Through More Reports Similar to the Global Prenatal Testing & Newborn Screening Market 2026, By The Business Research Company

    Dna Sequencing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/dna-sequencing-global-market-report

    Next Generation Sequencing Market

    https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market

    Protein Sequencing Market Report

    https://www.thebusinessresearchcompany.com/report/protein-sequencing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Prenatal Testing & Newborn Screening Market Expected to Reach $12.22 Billion by 2030 with 11.8% CAGR

    Global Prenatal Testing & Newborn Screening Market Expected to Reach $12.22 Billion by 2030 with 11.8% CAGR

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    What Market Value Is Anticipated For The Prenatal Testing & Newborn Screening Market Over The Period 2026–2030?

    The prenatal testing & newborn screening market size has experienced rapid expansion in recent years. It is projected to grow from $6.98 billion in 2025 to $7.84 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 12.3%. The growth observed in prior periods can be attributed to the broader reach of public health screening initiatives, an increase in institutional births, the availability of neonatal care facilities, a heightened emphasis on early disease detection, and enhancements in diagnostic testing coverage.

    The prenatal testing & newborn screening market size is anticipated to undergo rapid expansion in the coming years. It is forecast to reach $12.22 billion by 2030, growing at a compound annual growth rate (CAGR) of 11.8%. The projected growth in this period stems from factors such as the increasing reach of national screening mandates, the rising adoption of digital diagnostic platforms, growing investments in maternal and child healthcare, an increasing emphasis on preventive healthcare models, and the expanding utilization of AI-assisted diagnostics. Key trends expected during the forecast period include the increasing uptake of integrated prenatal and newborn screening programs, the rising application of combined screening and diagnostic technologies, the growing implementation of early intervention protocols, the expansion of automated screening workflows, and an enhanced focus on population-wide screening.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3350&type=smp

    What Underlying Factors Are Accelerating The Growth Of The Prenatal Testing & Newborn Screening Market?

    A high incidence of genetic diseases in infants has been a major contributor to the expansion of the prenatal testing & newborn screening market. The World Health Organization identifies various genetic conditions, including Thalassemia, Sickle Cell Anemia, Hemophilia, Cystic Fibrosis, Tay Sachs disease, Fragile X Syndrome, and Huntington’s disease. Sickle cell anemia, in particular, affects millions globally and is highly prevalent among populations with ancestral ties to Africa, America, Cuba, Central America, Saudi Arabia, and India. For instance, a study at Rady Children’s Hospital, as reported by the US-based Rady Children’s Institute for Genomic Medicine in February 2023, indicated that single-locus (Mendelian) genetic diseases accounted for 41% of infant deaths. This widespread occurrence of genetic diseases in babies has significantly boosted the demand for the prenatal testing and newborn screening market.

    Prenatal Testing & Newborn Screening Market Driver: Rising Birth Rate Fuels Growth Of Prenatal Testing And Newborn Screening Market

    How Is The Prenatal Testing & Newborn Screening Market Divided Into Its Major Segments?

    The prenatal testing & newborn screening market covered in this report is segmented –

    1) By Diagnostic Type: Non-Invasive, Invasive

    2) By Technology: Screening Technology, Diagnostic Technology

    3) By End User: Hospitals, Diagnostic centers

    Subsegments:

    1) By Non-Invasive: Blood Tests (Cell-Free DNA Testing), Ultrasound, Maternal Serum Screening

    2) By Invasive: Amniocentesis, Chorionic Villus Sampling (CVS), Cordocentesis

    What Major Market Trends Are Driving Changes In The Prenatal Testing & Newborn Screening Market?

    Companies operating within the prenatal testing & newborn screening market are primarily focused on developing newborn screening devices to enhance the early detection of genetic, metabolic, and other health conditions, thereby enabling timely interventions and improved health outcomes for newborns. A newborn screening point-of-care device is engineered to deliver faster, more accessible, and cost-effective screening for newborns, accommodating the seven standard newborn screening tests conducted globally. For instance, in September 2023, Mylab Discovery Solutions Pvt. Ltd., an Indian-based company, launched MyNeoShield, a newborn screening point-of-care device. MyNeoShield is designed to be low-cost, estimated to be about one-fifth the price of existing solutions, which often range from ₹50 lakhs to ₹7 crores. By bringing testing directly to healthcare providers, MyNeoShield aims to improve access to critical health services for newborns, particularly in underserved regions.

    Who Are The Prominent Organizations Shaping The Prenatal Testing & Newborn Screening Market?

    Major companies operating in the prenatal testing & newborn screening market are PerkinElmer Inc, Laboratory Corporation Of America Holdings, Natera Inc, Invitae Corporation, Centogene AG, Cradle Genomics Inc, Roche Diagnostics International AG, Quest Diagnostics Incorporated, Baebies Inc, Progenity Inc, Ravgen Inc, Strand Life Sciences Pvt Ltd, Eurofins Scientific, Illumina Inc, Agilent Technologies Inc, Thermo Fisher Scientific Inc, F Hoffmann La Roche Ltd, Bio Rad Laboratories Inc, Siemens Healthineers AG, BGI Group, QIAGEN NV, Ariosa Diagnostics Inc, Verinata Health Inc, Counsyl A Myriad Company, GenPath Diagnostics, Sonic Healthcare Limited, Cepheid A Danaher Company

    Read the full prenatal testing & newborn screening market report here:

    https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report

    Which Region Is Projected To Dominate The Prenatal Testing & Newborn Screening Market During The Forecast Period?

    North America was the largest region in the prenatal testing & newborn screening market in 2025. Western Europe was the second largest region in the prenatal testing and newborn screening market. The regions covered in the prenatal testing & newborn screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Prenatal Testing & Newborn Screening Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=3350&type=smp

    Browse Through More Reports Similar to the Global Prenatal Testing & Newborn Screening Market 2026, By The Business Research Company

    Dna Sequencing Global Market Report

    https://www.thebusinessresearchcompany.com/report/dna-sequencing-global-market-report

    Next Generation Sequencing Market

    https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market

    Protein Sequencing Global Market Report

    https://www.thebusinessresearchcompany.com/report/protein-sequencing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Prenatal Testing & Newborn Screening Industry Growth Insights: Revenue Forecast to 2030

    Prenatal Testing & Newborn Screening Industry Growth Insights: Revenue Forecast to 2030

    Uncover key drivers, emerging technologies, and competitive movements shaping the prenatal testing & newborn screening market from 2026–2035 with trusted insights from The Business Research Company

    What long-term size projections exist for the Prenatal Testing & Newborn Screening Market covering 2026–2035?

    The prenatal testing & newborn screening market size has seen substantial growth recently. It is anticipated to expand from $6.98 billion in 2025 to $7.84 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.3%. This historical growth can be linked to the broadening of public health screening initiatives, an increase in institutional births, the presence of neonatal care facilities, a heightened focus on early disease detection, and improvements in diagnostic testing coverage.

    The prenatal testing & newborn screening market is anticipated to experience substantial growth over the coming years, with its size projected to reach $12.22 billion by 2030, achieving a compound annual growth rate (CAGR) of 11.8%. This expansion during the forecast period is driven by several factors, including the increasing reach of national screening mandates, the rising incorporation of digital diagnostic platforms, augmented investments in maternal and child healthcare, a heightened emphasis on preventive healthcare models, and the expanding utilization of AI-assisted diagnostics. Significant trends anticipated for this period involve the increasing integration of prenatal and newborn screening programs, a growing use of combined screening and diagnostic technologies, the wider implementation of early intervention protocols, the expansion of automated screening workflows, and an intensified focus on population-wide screening efforts.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3350&type=smp

    Which Drivers Are Impacting The Competitive Landscape Of The Prenatal Testing & Newborn Screening Market?

    The high incidence of genetic conditions in infants has been a contributing factor to the expansion of the prenatal testing & newborn screening market. The World Health Organization identifies various genetic diseases, including Thalassemia, Sickle Cell Anemia, Hemophilia, Cystic Fibrosis, Tay Sachs disease, Fragile X Syndrome, and Huntington’s disease. Sickle cell anemia, a genetic disorder, impacts millions globally and is particularly common among individuals whose ancestors originate from Africa, America, Cuba, Central America, Saudi Arabia, and India. For instance, in February 2023, a study conducted at Rady Children’s Hospital by the US-based Rady Children’s Institute for Genomic Medicine reported that 41% of infant deaths were attributed to single-locus (Mendelian) genetic diseases. This significant prevalence of genetic diseases in infants has boosted the demand for the growth of the prenatal testing and newborn screening market. Prenatal Testing & Newborn Screening Market Driver: Rising Birth Rate Fuels Growth Of Prenatal Testing And Newborn Screening Market

    What Segments Are Identified Within The Structure Of The Prenatal Testing & Newborn Screening Market?

    The prenatal testing & newborn screening market covered in this report is segmented –

    1) By Diagnostic Type: Non-Invasive, Invasive

    2) By Technology: Screening Technology, Diagnostic Technology

    3) By End User: Hospitals, Diagnostic centers

    Subsegments:

    1) By Non-Invasive: Blood Tests (Cell-Free DNA Testing), Ultrasound, Maternal Serum Screening

    2) By Invasive: Amniocentesis, Chorionic Villus Sampling (CVS), Cordocentesis

    Which Trends Are Expected To Influence The Prenatal Testing & Newborn Screening Market In The Upcoming Years?

    Leading companies within the prenatal testing & newborn screening market are prioritizing the development of newborn screening devices to improve the early identification of genetic, metabolic, and other health conditions. This focus enables prompt interventions and enhances health outcomes for newborns. Newborn screening point-of-care devices are specifically designed to offer quicker, more accessible, and economical screening for infants, capable of performing the seven globally recognized standard newborn screening tests. As an illustration, in September 2023, Mylab Discovery Solutions Pvt. Ltd., an Indian company, introduced MyNeoShield, a new newborn screening point-of-care device. MyNeoShield is intended to be cost-effective, with an estimated price of about one-fifth of existing solutions, which typically cost between ?50 lakhs and ?7 crores. By making testing directly available to healthcare providers, MyNeoShield seeks to expand access to crucial health services for newborns, especially in areas with limited resources.

    Which Key Market Players Are Investing In Expansion And Innovation Within The Prenatal Testing & Newborn Screening Market?

    Major companies operating in the prenatal testing & newborn screening market are PerkinElmer Inc, Laboratory Corporation Of America Holdings, Natera Inc, Invitae Corporation, Centogene AG, Cradle Genomics Inc, Roche Diagnostics International AG, Quest Diagnostics Incorporated, Baebies Inc, Progenity Inc, Ravgen Inc, Strand Life Sciences Pvt Ltd, Eurofins Scientific, Illumina Inc, Agilent Technologies Inc, Thermo Fisher Scientific Inc, F Hoffmann La Roche Ltd, Bio Rad Laboratories Inc, Siemens Healthineers AG, BGI Group, QIAGEN NV, Ariosa Diagnostics Inc, Verinata Health Inc, Counsyl A Myriad Company, GenPath Diagnostics, Sonic Healthcare Limited, Cepheid A Danaher Company

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report

    Which Regions Are Poised For Strategic Growth In The Prenatal Testing & Newborn Screening Market?

    North America was the largest region in the prenatal testing & newborn screening market in 2025. Western Europe was the second largest region in the prenatal testing and newborn screening market. The regions covered in the prenatal testing & newborn screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Prenatal Testing & Newborn Screening Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=3350&type=smp

    Browse Through More Reports Similar to the Global Prenatal Testing & Newborn Screening Market 2026, By The Business Research Company

    Pediatric And Neonatal Testing Kit Market Report 2026

    https://www.thebusinessresearchcompany.com/report/pediatric-and-neonatal-testing-kit-global-market-report

    Prenatal And Newborn Genetic Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/prenatal-and-newborn-genetic-testing-global-market-report

    Non Invasive Prenatal Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/non-invasive-prenatal-testing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Prenatal Testing & Newborn Screening Industry Growth Insights: Revenue Forecast to 2030

    Prenatal Testing & Newborn Screening Industry Growth Insights: Revenue Forecast to 2030

    Uncover key drivers, emerging technologies, and competitive movements shaping the prenatal testing & newborn screening market from 2026–2035 with trusted insights from The Business Research Company

    What long-term size projections exist for the Prenatal Testing & Newborn Screening Market covering 2026–2035?

    The prenatal testing & newborn screening market size has seen substantial growth recently. It is anticipated to expand from $6.98 billion in 2025 to $7.84 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.3%. This historical growth can be linked to the broadening of public health screening initiatives, an increase in institutional births, the presence of neonatal care facilities, a heightened focus on early disease detection, and improvements in diagnostic testing coverage.

    The prenatal testing & newborn screening market is anticipated to experience substantial growth over the coming years, with its size projected to reach $12.22 billion by 2030, achieving a compound annual growth rate (CAGR) of 11.8%. This expansion during the forecast period is driven by several factors, including the increasing reach of national screening mandates, the rising incorporation of digital diagnostic platforms, augmented investments in maternal and child healthcare, a heightened emphasis on preventive healthcare models, and the expanding utilization of AI-assisted diagnostics. Significant trends anticipated for this period involve the increasing integration of prenatal and newborn screening programs, a growing use of combined screening and diagnostic technologies, the wider implementation of early intervention protocols, the expansion of automated screening workflows, and an intensified focus on population-wide screening efforts.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3350&type=smp

    Which Drivers Are Impacting The Competitive Landscape Of The Prenatal Testing & Newborn Screening Market?

    The high incidence of genetic conditions in infants has been a contributing factor to the expansion of the prenatal testing & newborn screening market. The World Health Organization identifies various genetic diseases, including Thalassemia, Sickle Cell Anemia, Hemophilia, Cystic Fibrosis, Tay Sachs disease, Fragile X Syndrome, and Huntington’s disease. Sickle cell anemia, a genetic disorder, impacts millions globally and is particularly common among individuals whose ancestors originate from Africa, America, Cuba, Central America, Saudi Arabia, and India. For instance, in February 2023, a study conducted at Rady Children’s Hospital by the US-based Rady Children’s Institute for Genomic Medicine reported that 41% of infant deaths were attributed to single-locus (Mendelian) genetic diseases. This significant prevalence of genetic diseases in infants has boosted the demand for the growth of the prenatal testing and newborn screening market. Prenatal Testing & Newborn Screening Market Driver: Rising Birth Rate Fuels Growth Of Prenatal Testing And Newborn Screening Market

    What Segments Are Identified Within The Structure Of The Prenatal Testing & Newborn Screening Market?

    The prenatal testing & newborn screening market covered in this report is segmented –

    1) By Diagnostic Type: Non-Invasive, Invasive

    2) By Technology: Screening Technology, Diagnostic Technology

    3) By End User: Hospitals, Diagnostic centers

    Subsegments:

    1) By Non-Invasive: Blood Tests (Cell-Free DNA Testing), Ultrasound, Maternal Serum Screening

    2) By Invasive: Amniocentesis, Chorionic Villus Sampling (CVS), Cordocentesis

    Which Trends Are Expected To Influence The Prenatal Testing & Newborn Screening Market In The Upcoming Years?

    Leading companies within the prenatal testing & newborn screening market are prioritizing the development of newborn screening devices to improve the early identification of genetic, metabolic, and other health conditions. This focus enables prompt interventions and enhances health outcomes for newborns. Newborn screening point-of-care devices are specifically designed to offer quicker, more accessible, and economical screening for infants, capable of performing the seven globally recognized standard newborn screening tests. As an illustration, in September 2023, Mylab Discovery Solutions Pvt. Ltd., an Indian company, introduced MyNeoShield, a new newborn screening point-of-care device. MyNeoShield is intended to be cost-effective, with an estimated price of about one-fifth of existing solutions, which typically cost between ?50 lakhs and ?7 crores. By making testing directly available to healthcare providers, MyNeoShield seeks to expand access to crucial health services for newborns, especially in areas with limited resources.

    Which Key Market Players Are Investing In Expansion And Innovation Within The Prenatal Testing & Newborn Screening Market?

    Major companies operating in the prenatal testing & newborn screening market are PerkinElmer Inc, Laboratory Corporation Of America Holdings, Natera Inc, Invitae Corporation, Centogene AG, Cradle Genomics Inc, Roche Diagnostics International AG, Quest Diagnostics Incorporated, Baebies Inc, Progenity Inc, Ravgen Inc, Strand Life Sciences Pvt Ltd, Eurofins Scientific, Illumina Inc, Agilent Technologies Inc, Thermo Fisher Scientific Inc, F Hoffmann La Roche Ltd, Bio Rad Laboratories Inc, Siemens Healthineers AG, BGI Group, QIAGEN NV, Ariosa Diagnostics Inc, Verinata Health Inc, Counsyl A Myriad Company, GenPath Diagnostics, Sonic Healthcare Limited, Cepheid A Danaher Company

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report

    Which Regions Are Poised For Strategic Growth In The Prenatal Testing & Newborn Screening Market?

    North America was the largest region in the prenatal testing & newborn screening market in 2025. Western Europe was the second largest region in the prenatal testing and newborn screening market. The regions covered in the prenatal testing & newborn screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Prenatal Testing & Newborn Screening Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=3350&type=smp

    Browse Through More Reports Similar to the Global Prenatal Testing & Newborn Screening Market 2026, By The Business Research Company

    Pediatric And Neonatal Testing Kit Market Report 2026

    https://www.thebusinessresearchcompany.com/report/pediatric-and-neonatal-testing-kit-global-market-report

    Prenatal And Newborn Genetic Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/prenatal-and-newborn-genetic-testing-global-market-report

    Non Invasive Prenatal Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/non-invasive-prenatal-testing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Prenatal Testing & Newborn Screening Industry Growth Insights: Revenue Forecast to 2030

    Prenatal Testing & Newborn Screening Industry Growth Insights: Revenue Forecast to 2030

    Uncover key drivers, emerging technologies, and competitive movements shaping the prenatal testing & newborn screening market from 2026–2035 with trusted insights from The Business Research Company

    What long-term size projections exist for the Prenatal Testing & Newborn Screening Market covering 2026–2035?

    The prenatal testing & newborn screening market size has seen substantial growth recently. It is anticipated to expand from $6.98 billion in 2025 to $7.84 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.3%. This historical growth can be linked to the broadening of public health screening initiatives, an increase in institutional births, the presence of neonatal care facilities, a heightened focus on early disease detection, and improvements in diagnostic testing coverage.

    The prenatal testing & newborn screening market is anticipated to experience substantial growth over the coming years, with its size projected to reach $12.22 billion by 2030, achieving a compound annual growth rate (CAGR) of 11.8%. This expansion during the forecast period is driven by several factors, including the increasing reach of national screening mandates, the rising incorporation of digital diagnostic platforms, augmented investments in maternal and child healthcare, a heightened emphasis on preventive healthcare models, and the expanding utilization of AI-assisted diagnostics. Significant trends anticipated for this period involve the increasing integration of prenatal and newborn screening programs, a growing use of combined screening and diagnostic technologies, the wider implementation of early intervention protocols, the expansion of automated screening workflows, and an intensified focus on population-wide screening efforts.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3350&type=smp

    Which Drivers Are Impacting The Competitive Landscape Of The Prenatal Testing & Newborn Screening Market?

    The high incidence of genetic conditions in infants has been a contributing factor to the expansion of the prenatal testing & newborn screening market. The World Health Organization identifies various genetic diseases, including Thalassemia, Sickle Cell Anemia, Hemophilia, Cystic Fibrosis, Tay Sachs disease, Fragile X Syndrome, and Huntington’s disease. Sickle cell anemia, a genetic disorder, impacts millions globally and is particularly common among individuals whose ancestors originate from Africa, America, Cuba, Central America, Saudi Arabia, and India. For instance, in February 2023, a study conducted at Rady Children’s Hospital by the US-based Rady Children’s Institute for Genomic Medicine reported that 41% of infant deaths were attributed to single-locus (Mendelian) genetic diseases. This significant prevalence of genetic diseases in infants has boosted the demand for the growth of the prenatal testing and newborn screening market. Prenatal Testing & Newborn Screening Market Driver: Rising Birth Rate Fuels Growth Of Prenatal Testing And Newborn Screening Market

    What Segments Are Identified Within The Structure Of The Prenatal Testing & Newborn Screening Market?

    The prenatal testing & newborn screening market covered in this report is segmented –

    1) By Diagnostic Type: Non-Invasive, Invasive

    2) By Technology: Screening Technology, Diagnostic Technology

    3) By End User: Hospitals, Diagnostic centers

    Subsegments:

    1) By Non-Invasive: Blood Tests (Cell-Free DNA Testing), Ultrasound, Maternal Serum Screening

    2) By Invasive: Amniocentesis, Chorionic Villus Sampling (CVS), Cordocentesis

    Which Trends Are Expected To Influence The Prenatal Testing & Newborn Screening Market In The Upcoming Years?

    Leading companies within the prenatal testing & newborn screening market are prioritizing the development of newborn screening devices to improve the early identification of genetic, metabolic, and other health conditions. This focus enables prompt interventions and enhances health outcomes for newborns. Newborn screening point-of-care devices are specifically designed to offer quicker, more accessible, and economical screening for infants, capable of performing the seven globally recognized standard newborn screening tests. As an illustration, in September 2023, Mylab Discovery Solutions Pvt. Ltd., an Indian company, introduced MyNeoShield, a new newborn screening point-of-care device. MyNeoShield is intended to be cost-effective, with an estimated price of about one-fifth of existing solutions, which typically cost between ?50 lakhs and ?7 crores. By making testing directly available to healthcare providers, MyNeoShield seeks to expand access to crucial health services for newborns, especially in areas with limited resources.

    Which Key Market Players Are Investing In Expansion And Innovation Within The Prenatal Testing & Newborn Screening Market?

    Major companies operating in the prenatal testing & newborn screening market are PerkinElmer Inc, Laboratory Corporation Of America Holdings, Natera Inc, Invitae Corporation, Centogene AG, Cradle Genomics Inc, Roche Diagnostics International AG, Quest Diagnostics Incorporated, Baebies Inc, Progenity Inc, Ravgen Inc, Strand Life Sciences Pvt Ltd, Eurofins Scientific, Illumina Inc, Agilent Technologies Inc, Thermo Fisher Scientific Inc, F Hoffmann La Roche Ltd, Bio Rad Laboratories Inc, Siemens Healthineers AG, BGI Group, QIAGEN NV, Ariosa Diagnostics Inc, Verinata Health Inc, Counsyl A Myriad Company, GenPath Diagnostics, Sonic Healthcare Limited, Cepheid A Danaher Company

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report

    Which Regions Are Poised For Strategic Growth In The Prenatal Testing & Newborn Screening Market?

    North America was the largest region in the prenatal testing & newborn screening market in 2025. Western Europe was the second largest region in the prenatal testing and newborn screening market. The regions covered in the prenatal testing & newborn screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Prenatal Testing & Newborn Screening Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=3350&type=smp

    Browse Through More Reports Similar to the Global Prenatal Testing & Newborn Screening Market 2026, By The Business Research Company

    Pediatric And Neonatal Testing Kit Market Report 2026

    https://www.thebusinessresearchcompany.com/report/pediatric-and-neonatal-testing-kit-global-market-report

    Prenatal And Newborn Genetic Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/prenatal-and-newborn-genetic-testing-global-market-report

    Non Invasive Prenatal Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/non-invasive-prenatal-testing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Which Emerging Trends Are Driving The Prenatal Testing & Newborn Screening Market Toward $10.99 Billion By 2029?

    Which Emerging Trends Are Driving The Prenatal Testing & Newborn Screening Market Toward $10.99 Billion By 2029?

    Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

    How Is The Prenatal Testing & Newborn Screening Market Expected To Grow In Terms Of Size?

    In recent times, the prenatal testing & newborn screening market has witnessed quick expansion. Currently valued at $6.24 billion in 2024, it is projected to escalate to $6.98 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 11.8%. The previous period of growth can be credited mainly to the improvements in genetic testing, a rise in maternal age, amplified awareness and education, and evolving healthcare policies and regulations.

    The market for prenatal testing & newborn screening is predicted to experience rapid expansion in the coming years. This market is set to reach a value of $10.99 billion by 2029, with a compound annual growth rate (CAGR) of 12.0%. The projected growth during the forecast period can be ascribed to factors such as genetic counseling, technological progress, point-of-care testing, telehealth, and remote monitoring. Other significant trends expected during this period entail non-invasive prenatal testing (nipt), preimplantation genetic testing (pgt), telemedicine consultations, testing of maternal blood, as well as screening for hemoglobinopathies and sickle cell.

    Get A Free Sample Of The Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3350&type=smp

    Which Key Factors Are Fueling Growth In The Prenatal Testing & Newborn Screening Market?

    The high incidence of genetic disorders in babies has fueled the expansion of the prenatal testing & newborn screening market. Genetic diseases, as defined by the World Health Organization, comprise Thalassemia, Sickle Cell Anemia, Hemophilia, Cystic Fibrosis, Tay Sachs disease, Fragile X Syndrome, and Huntington’s disease among others. Sickle cell anemia, a genetic disease, impacts millions worldwide, especially those with ancestral roots in Africa, America, Cuba, Central America, Saudi Arabia, and India. For example, a study conducted at Rady Children’s Hospital by the Rady Children’s Institute for Genomic Medicine, a US research institute, in February 2023 revealed that 41% of infant deaths were due to single-locus (Mendelian) genetic diseases. Such high occurrence of genetic disorders in babies has amplified the demand and subsequently the growth of the prenatal testing and newborn screening market.

    How Is The Prenatal Testing & Newborn Screening Market Categorized Across Applications And Types?

    The prenatal testing & newborn screeningmarket covered in this report is segmented –

    1) By Diagnostic Type: Non-Invasive; Invasive

    2) By Technology: Screening Technology; Diagnostic Technology

    3) By End user: Hospitals; Diagnostic centers

    Subsegments:

    1) By Non-Invasive: Blood Tests (Cell-Free DNA Testing); Ultrasound; Maternal Serum Screening

    2) By Invasive: Amniocentesis; Chorionic Villus Sampling (CVS); Cordocentesis

    How Are Industry Trends Steering The Expansion Of The Prenatal Testing & Newborn Screening Market?

    Top players in the prenatal testing & newborn screening market are making strides towards implementing innovative programs that leverage rWGS (rapid Whole Genome Sequencing) technology. This cutting-edge technology enables swift and precise detection of genetic abnormalities in newborns, facilitating timely diagnosis and treatment and thereby improving health outcomes. Unlike traditional genetic tests that focus on specific genes or regions, rWGS technology sequences the complete genome of an individual, identifying genetic variations related to diseases or health conditions. For example, Rady Children’s Institute for Genomic Medicine, a US company, rolled out BeginNGS, a groundbreaking program in June 2022. This initiative aims to pinpoint and diagnose around 400 treatable genetic conditions before they start showing symptoms. BeginNGS is in the process of enhancing genomic sequencing procedures with the objective to widen its testing capabilities to manage nearly 1,000 disorders. The long-term goal is to standardize screening for 3.7 million newborns per year across hospitals nationwide.

    Which Firms Are Making The Biggest Impact In The Prenatal Testing & Newborn Screening Market?

    Major companies operating in the prenatal testing & newborn screening market include PerkinElmer Inc., Laboratory Corporation of America Holdings (LabCorp), Natera Inc., Invitae Corporation, Centogene AG, Cradle Genomics Inc., Roche Diagnostics International AG, Quest Diagnostics Incorporated, Baebies Inc., Progenity Inc., Ravgen Inc., Strand Life Sciences Pvt. Ltd., Eurofins Scientific, Illumina Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories Inc., General Electric Company, Siemens Healthineers AG, BGI Group, QIAGEN N.V., Veracyte Inc., NIPD Genetics, Novacyt UK, Ariosa Diagnostics Inc., Verinata Health Inc., Counsyl a Myriad Company, GenPath Diagnostics, Sonic Healthcare Limited, Cepheid a Danaher Company, Guardant Health Inc., Genetron Health (Beijing) Co. Ltd.

    Access The Complete Report Here:

    https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report

    Which Region Holds The Greatest Opportunity For Prenatal Testing & Newborn Screening Market Expansion?

    North America was the largest region in the prenatal testing & newborn screening market in 2024. Western Europe was the second largest region in the prenatal testing and newborn screening market. The regions covered in the prenatal testing & newborn screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Customize Your Report Here:

    https://www.thebusinessresearchcompany.com/customise?id=3350&type=smp

    Browse Through More Reports Similar to the Global Prenatal Testing & Newborn Screening Market 2025, By The Business Research Company

    Non Invasive Prenatal Testing Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/non-invasive-prenatal-testing-global-market-report

    Testing Inspection And Certification Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/testing-inspection-and-certification-global-market-report

    Genetic Testing Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Prenatal Testing & Newborn Screening Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

    Prenatal Testing & Newborn Screening Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    What is the Projected CAGR for the Prenatal Testing & Newborn Screening Market Size from 2025 to 2034?

    In recent times, the market size for prenatal testing & newborn screening has experienced a swift expansion. There will be a growth from $6.24 billion in 2024 to $6.98 billion in 2025, representing a compound annual growth rate (CAGR) of 11.8%. This growth during the historical period is the result of advancements in genetic testing, escalation in maternal age, elevated awareness and education, along with healthcare policy and regulations.

    In the coming years, a swift expansion is predicted in the prenatal testing & newborn screening market. The market is forecasted to reach a value of$10.99 billion in 2029, expanding at a compound annual growth rate (CAGR) of 12.0%. Factors such as genetic counseling, cutting-edge technology, point-of-care testing, telehealth and remote monitoring are leading the growth in the forecast period. Key trends for this period include non-invasive prenatal testing (nipt), preimplantation genetic testing (pgt), telemedicine consultations, maternal blood testing, hemoglobinopathies, and sickle cell screening.

    Download a free sample to assess the report’s scope and structure:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3350&type=smp

    What External and Internal Drivers Are Contributing to the Growth of thePrenatal Testing & Newborn Screening Market?

    The escalation in the occurrences of genetic illnesses in infants has fostered the expansion of the prenatal testing & newborn screening market. Diseases such as Thalassemia, Sickle Cell Anemia, Hemophilia, Cystic Fibrosis, Tay Sachs disease, Fragile X Syndrome, and Huntington’s disease are included in genetic diseases as per the World Health Organization. Sickle cell anemia, a genetic disease, is widespread, affecting millions globally, especially those with ancestors from Africa, America, Cuba, Central America, Saudi Arabia, and India. A study undertaken at Rady Children’s Hospital by the US-based Rady Children’s Institute for Genomic Medicine, in February 2023, highlighted that 41% of infant fatalities were due to single-locus (Mendelian) genetic diseases. This significant rate of genetic diseases in infants has driven the demand for growth in the prenatal testing and newborn screening market.

    What Segment Types Define the Prenatal Testing & Newborn Screening Market Structure?

    The prenatal testing & newborn screeningmarket covered in this report is segmented –

    1) By Diagnostic Type: Non-Invasive; Invasive

    2) By Technology: Screening Technology; Diagnostic Technology

    3) By End user: Hospitals; Diagnostic centers

    Subsegments:

    1) By Non-Invasive: Blood Tests (Cell-Free DNA Testing); Ultrasound; Maternal Serum Screening

    2) By Invasive: Amniocentesis; Chorionic Villus Sampling (CVS); Cordocentesis

    Request customized data on this market:

    https://www.thebusinessresearchcompany.com/customise?id=3350&type=smp

    Which Geographic Areas Hold the Strongest Growth Potential in the Prenatal Testing & Newborn Screening Market?

    North America was the largest region in the prenatal testing & newborn screening market in 2024. Western Europe was the second largest region in the prenatal testing and newborn screening market. The regions covered in the prenatal testing & newborn screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    What Long-Term Trends Are Transforming the Competitive Landscape of the Prenatal Testing & Newborn Screening Market?

    Leading firms engaged in the prenatal testing & neonatal screening market are concentrating on launching innovative systems that use rWGS (rapid Whole Genome Sequencing) technology for swift and precise detection of genetic disorders in newborns, thereby facilitating early detection and intervention for better health outcomes. rWGS technology is a state-of-the-art genomic method that instantaneously sequences the whole genome of a person. It is different from conventional genetic testing techniques that focus on distinct genes or regions as rWGS identifies all DNA in a person’s genome to recognize genetic discrepancies linked to diseases or disorders. For example, in June 2022, BeginNGS, a new program, was initiated by Rady Children’s Institute for Genomic Medicine, a firm based in the US. This endeavor aims at identifying and diagnosing about 400 genetic disorders that have recognizable treatment options before symptoms occur. BeginNGS is working on enhancing genomic sequencing procedures with strategies to increase testing competencies to include roughly 1,000 disorders. The long-term objective is to facilitate screening for around 3.7 million newborns every year, aiming to standardize this practice in hospitals all over the country.

    View the full report here:

    https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report

    What Is the Definition of the Prenatal Testing & Newborn Screening Market?

    Prenatal testing and newborn screening refer to the combined medical practices aimed at assessing the health of both the fetus during pregnancy and the newborn after birth. Prenatal testing includes various assessments, such as blood tests and ultrasounds, to identify potential genetic or developmental disorders in the fetus. Newborn screening involves conducting tests shortly after birth to detect metabolic, genetic, and endocrine disorders, allowing for early intervention and treatment to improve health outcomes for infants.

    Purchase the full report and get a swift delivery:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3350

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Europe +44 7882 955267

    Asia & Others +44 7882 955267 & +91 8897263534

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Prenatal Testing & Newborn Screening Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

    Prenatal Testing & Newborn Screening Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    What is the Projected CAGR for the Prenatal Testing & Newborn Screening Market Size from 2025 to 2034?

    In recent times, the market size for prenatal testing & newborn screening has experienced a swift expansion. There will be a growth from $6.24 billion in 2024 to $6.98 billion in 2025, representing a compound annual growth rate (CAGR) of 11.8%. This growth during the historical period is the result of advancements in genetic testing, escalation in maternal age, elevated awareness and education, along with healthcare policy and regulations.

    In the coming years, a swift expansion is predicted in the prenatal testing & newborn screening market. The market is forecasted to reach a value of$10.99 billion in 2029, expanding at a compound annual growth rate (CAGR) of 12.0%. Factors such as genetic counseling, cutting-edge technology, point-of-care testing, telehealth and remote monitoring are leading the growth in the forecast period. Key trends for this period include non-invasive prenatal testing (nipt), preimplantation genetic testing (pgt), telemedicine consultations, maternal blood testing, hemoglobinopathies, and sickle cell screening.

    Download a free sample to assess the report’s scope and structure:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3350&type=smp

    What External and Internal Drivers Are Contributing to the Growth of thePrenatal Testing & Newborn Screening Market?

    The escalation in the occurrences of genetic illnesses in infants has fostered the expansion of the prenatal testing & newborn screening market. Diseases such as Thalassemia, Sickle Cell Anemia, Hemophilia, Cystic Fibrosis, Tay Sachs disease, Fragile X Syndrome, and Huntington’s disease are included in genetic diseases as per the World Health Organization. Sickle cell anemia, a genetic disease, is widespread, affecting millions globally, especially those with ancestors from Africa, America, Cuba, Central America, Saudi Arabia, and India. A study undertaken at Rady Children’s Hospital by the US-based Rady Children’s Institute for Genomic Medicine, in February 2023, highlighted that 41% of infant fatalities were due to single-locus (Mendelian) genetic diseases. This significant rate of genetic diseases in infants has driven the demand for growth in the prenatal testing and newborn screening market.

    What Segment Types Define the Prenatal Testing & Newborn Screening Market Structure?

    The prenatal testing & newborn screeningmarket covered in this report is segmented –

    1) By Diagnostic Type: Non-Invasive; Invasive

    2) By Technology: Screening Technology; Diagnostic Technology

    3) By End user: Hospitals; Diagnostic centers

    Subsegments:

    1) By Non-Invasive: Blood Tests (Cell-Free DNA Testing); Ultrasound; Maternal Serum Screening

    2) By Invasive: Amniocentesis; Chorionic Villus Sampling (CVS); Cordocentesis

    Request customized data on this market:

    https://www.thebusinessresearchcompany.com/customise?id=3350&type=smp

    Which Geographic Areas Hold the Strongest Growth Potential in the Prenatal Testing & Newborn Screening Market?

    North America was the largest region in the prenatal testing & newborn screening market in 2024. Western Europe was the second largest region in the prenatal testing and newborn screening market. The regions covered in the prenatal testing & newborn screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    What Long-Term Trends Are Transforming the Competitive Landscape of the Prenatal Testing & Newborn Screening Market?

    Leading firms engaged in the prenatal testing & neonatal screening market are concentrating on launching innovative systems that use rWGS (rapid Whole Genome Sequencing) technology for swift and precise detection of genetic disorders in newborns, thereby facilitating early detection and intervention for better health outcomes. rWGS technology is a state-of-the-art genomic method that instantaneously sequences the whole genome of a person. It is different from conventional genetic testing techniques that focus on distinct genes or regions as rWGS identifies all DNA in a person’s genome to recognize genetic discrepancies linked to diseases or disorders. For example, in June 2022, BeginNGS, a new program, was initiated by Rady Children’s Institute for Genomic Medicine, a firm based in the US. This endeavor aims at identifying and diagnosing about 400 genetic disorders that have recognizable treatment options before symptoms occur. BeginNGS is working on enhancing genomic sequencing procedures with strategies to increase testing competencies to include roughly 1,000 disorders. The long-term objective is to facilitate screening for around 3.7 million newborns every year, aiming to standardize this practice in hospitals all over the country.

    View the full report here:

    https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report

    What Is the Definition of the Prenatal Testing & Newborn Screening Market?

    Prenatal testing and newborn screening refer to the combined medical practices aimed at assessing the health of both the fetus during pregnancy and the newborn after birth. Prenatal testing includes various assessments, such as blood tests and ultrasounds, to identify potential genetic or developmental disorders in the fetus. Newborn screening involves conducting tests shortly after birth to detect metabolic, genetic, and endocrine disorders, allowing for early intervention and treatment to improve health outcomes for infants.

    Purchase the full report and get a swift delivery:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3350

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Europe +44 7882 955267

    Asia & Others +44 7882 955267 & +91 8897263534

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Prenatal Testing & Newborn Screening Market Projected at $11.08 Billion by 2029 | Strategic Insights and Forecast Data

    Prenatal Testing & Newborn Screening Market Projected at $11.08 Billion by 2029 | Strategic Insights and Forecast Data

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    #How Has The Prenatal Testing & Newborn Screening Market Size Shifted, And What Is the Outlook Through 2034?

    In recent years, the market size for prenatal testing and newborn screening has seen rapid expansion. The predictions for growth place it at escalating from $6.24 billion in 2024 to $6.99 billion in 2025, indicating a compound annual growth rate (CAGR) of 12.0%. Elements contributing to this upward trend during the historical period include advancements in genetic testing, escalating maternal age, heightened awareness and education, and healthcare policies and regulations.

    How Much Will the Prenatal Testing & Newborn Screening Market Be Worth in 2029?

    Anticipated to experience swift expansion in the coming years, the market size of prenatal testing & newborn screening is predicted to mature to a value of $11.08 billion in 2029, boasting a compound annual growth rate (CAGR) of 12.2%. The acceleration in the forecast period is influenced by various factors such as genetic counseling, advancements in technology, point-of-care testing, along with telehealth and remote monitoring. During the forecast period, major trends are expected to encompass non-invasive prenatal testing (nipt), preimplantation genetic testing (pgt), telemedicine consultations, maternal blood testing, as well as hemoglobinopathies and sickle cell screening.

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3350&type=smp

    Which is the Largest Company in the Prenatal Testing & Newborn Screening Market?

    Major companies operating in the prenatal testing & newborn screening market include PerkinElmer Inc., Laboratory Corporation of America Holdings (LabCorp), Natera Inc., Invitae Corporation, Centogene AG, Cradle Genomics Inc., Roche Diagnostics International AG, Quest Diagnostics Incorporated, Baebies Inc., Progenity Inc., Ravgen Inc., Strand Life Sciences Pvt. Ltd., Eurofins Scientific, Illumina Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories Inc., General Electric Company, Siemens Healthineers AG, BGI Group, QIAGEN N.V., Veracyte Inc., NIPD Genetics, Novacyt UK, Ariosa Diagnostics Inc., Verinata Health Inc., Counsyl a Myriad Company, GenPath Diagnostics, Sonic Healthcare Limited, Cepheid a Danaher Company, Guardant Health Inc., Genetron Health (Beijing) Co. Ltd.

    What Are the Main Market Drivers in the Prenatal Testing & Newborn Screening Industry?

    The considerable incidence of hereditary conditions in babies has fueled the expansion of the prenatal testing & newborn screening market. The World Health Organization reveals that genetic illnesses encompass ailments such as Thalassemia, Sickle Cell Anemia, Hemophilia, Cystic Fibrosis, Tay Sachs disease, Fragile X Syndrome, Huntington’s disease. Among these, sickle cell anemia impacts millions globally, with the disease especially prevalent among individuals whose forefathers hailed from regions like Africa, America, Cuba, Central America, Saudi Arabia, and India. For instance, a study performed at Rady Children’s Hospital by the U.S based Rady Children’s Institute for Genomic Medicine in February 2023 revealed that 41% of infant fatalities were associated with single-locus (Mendelian) genetic diseases. This significant incidence of genetic conditions in infants has amplified the demand, thus fostering the growth of the prenatal testing and newborn screening market.

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/customise?id=3350&type=smp

    How Is the Prenatal Testing & Newborn Screening Market Segments Structured?

    The prenatal testing & newborn screening market covered in this report is segmented –

    1) By Diagnostic Type: Non-Invasive, Invasive

    2) By Technology: Screening Technology, Diagnostic Technology

    3) By End user: Hospitals, Diagnostic centers

    Subsegments:

    1) By Non-Invasive: Blood Tests (Cell-Free DNA Testing), Ultrasound, Maternal Serum Screening

    2) By Invasive: Amniocentesis, Chorionic Villus Sampling (CVS), Cordocentesis

    What Strategic Trends Are Transforming the Prenatal Testing & Newborn Screening Market?

    In the prenatal testing & newborn screening market, influential companies are placing a heavy emphasis on launching innovative programs that deploy rWGS (rapid Whole Genome Sequencing) technology. This advanced approach allows for swift and precise detection of genetic disorders in newborns, thus facilitating early prognosis and treatment to enhance health results. Unlike conventional gene testing techniques that only target specific genes or areas, rWGS examines the full genome of an individual, detecting genetic variations that could lead to diseases or disorders. For example, in June 2022, Rady Children’s Institute for Genomic Medicine, located in the US, introduced a ground-breaking program called BeginNGS. The program’s objective is to recognise and diagnose about 400 genetic disorders with existing treatment options before the disorders begin to show symptoms. BeginNGS is currently improving genomic sequencing procedures and plans to broaden its testing range to include about 1,000 disorders. The ultimate ambition is to make screening a standard procedure for 3.7 million newborns every year, across hospitals in the country.

    Access The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report

    Which Global Regions Offer the Highest Growth in the Prenatal Testing & Newborn Screening Market?

    North America was the largest region in the prenatal testing & newborn screening market in 2023. Western Europe was the second largest region in the prenatal testing and newborn screening market. The regions covered in the prenatal testing & newborn screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Purchase The Full Report Today:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3350

    This Report Delivers Insight On:

    1. How big is the prenatal testing & newborn screening market, and how is it changing globally?

    2. Who are the major companies in the prenatal testing & newborn screening market, and how are they performing?

    3. What are the key opportunities and risks in the prenatal testing & newborn screening market right now?

    4. Which products or customer segments are growing the most in the prenatal testing & newborn screening market?

    5. What factors are helping or slowing down the growth of the prenatal testing & newborn screening market?

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 2071930708

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model